US88167AAE10 - Teva Pharmaceutical Fin Neth 10/01/2026 3.150 Bond Stock - Stock Price, Institutional Ownership, Shareholders
Teva Issues Largest Ever Sustainability-Linked Bond Tied to Climate and Access to Medicine Goals - ESG Today
You cannot critique us for trying to help,' says Teva CEO on sustainability-linked bond launch
Teva Bonds: 8.8% Yield To Maturity Understates Upside (NYSE:TEVA) | Seeking Alpha
Teva finalises bond sale of $15bn
Teva's Debt Cut to Junk by Moody's, Adding to Drugmaker's Woes - Bloomberg
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva looks for $20B-plus from bond sale to finance Allergan deal | Fierce Pharma
Weapons for Liberty - Education Outreach - Tennessee Virtual Archive
TEVA | Market Realist
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva`s Bonds Rally on News of $4.35bn US Opioid Crisis Settlement
Teva Sells $15 Billion of Bonds - WSJ
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva lining up alone in EM bonds
Market Rover: 20 High Yield Bonds Selling-Off, These 3 Are Worth Considering — Blue Harbinger Investment Research
Teva Celebrates Pride with an Expansive Collection and Donation to the Human Rights Campaign Foundation
Teva Pharmaceuticals on X: "Teva announces new ESG targets addressing two of today's greatest global crises, access to medicines and climate change. Targets are tied to our recent issuance of a $5
S&P announced it had downgraded Teva's credit rating by one level - from BB to junk bonds :: Israeli Financial News - The Israeli Economic World
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
By selling bonds tied to drug access and climate goals, Teva takes pharma in a new direction - STAT
